Edition:
United Kingdom

Yield10 Bioscience Inc (YTEN.OQ)

YTEN.OQ on NASDAQ Stock Exchange Capital Market

1.63USD
3:50pm GMT
Change (% chg)

$0.06 (+3.82%)
Prev Close
$1.57
Open
$1.60
Day's High
$1.64
Day's Low
$1.58
Volume
20,450
Avg. Vol
64,840
52-wk High
$9.20
52-wk Low
$1.54

Chart for

About

Yield10 Bioscience, Inc., formerly Metabolix, Inc., is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant... (more)
No analyst recommendations are available for .

Overall

Beta: 3.60
Market Cap(Mil.): $11.16
Shares Outstanding(Mil.): 3.45
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 84.57 16.44
EPS (TTM): -- -- --
ROI: -- 3.42 10.61
ROE: -- 5.38 14.21

BRIEF-Yield10 Bioscience Announces Pricing Of $12.6 Mln Public Offering

* YIELD10 BIOSCIENCE ANNOUNCES PRICING OF $12.6 MILLION PUBLIC OFFERING

19 Dec 2017

BRIEF-Yield10 Bioscience Grants Research License To Monsanto To Evaluate Two Novel Yield Traits In Soybean

* YIELD10 BIOSCIENCE INC - ‍GRANTED A NON-EXCLUSIVE RESEARCH LICENSE TO MONSANTO COMPANY TO EVALUATE ITS NOVEL C3003 AND C3004 YIELD TRAITS IN SOYBEAN​

11 Dec 2017

BRIEF-Yield10 Bioscience posts Q3 loss $0.59/shr from continuing operations

* Yield10 Bioscience announces third quarter 2017 financial results

09 Nov 2017

BRIEF-‍Yield10 Bioscience obtains confirmation of nonregulated status from USDA-APHIS for its genome-edited Camelina line​

* ‍Yield10 bioscience obtains confirmation of nonregulated status from USDA-APHIS for its genome-edited Camelina line​ Source text for Eikon: Further company coverage:

05 Sep 2017

BRIEF-Yield10 Bioscience Q2 loss per share $0.96 from continuing operations

* Yield10 Bioscience announces second quarter 2017 financial results

10 Aug 2017

Earnings vs. Estimates